Characterization of a subtype of autoimmune encephalitis with anti-Contactin-Associated protein-like 2 antibodies in the cerebrospinal fluid, prominent limbic symptoms, and seizures

JAMA Neurology

Volumn 73, Issue 9, 2016, Pages 1115-1124

  Joubert, Bastien ^a,b,c   Saint Martin, Margaux ^b,c   Noraz, Nelly ^b,c   Picard, Géraldine ^a   Rogemond, Veronique ^b   Ducray, François ^b   Desestret, Virginie ^b   Psimaras, Dimitri ^d   Delattre, Jean Yves ^d   Antoine, Jean Christophe ^e   Honnorat, Jérôme ^b  

^a HÔPITAL NEUROLOGIQUE   (France)

^b UNIVERSITÉ DE LYON   (France)

^c UNIVERSITÉ LYON 1   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e UNIVERSITÉ JEAN MONNET   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CONTACTIN ASSOCIATED PROTEIN LIKE 2 ANTIBODY; CORTICOSTEROID; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; IMMUNOGLOBULIN G4; MYCOPHENOLATE MOFETIL; PROTEIN ANTIBODY; RITUXIMAB; STEROID; UNCLASSIFIED DRUG; AUTOANTIBODY; CNTNAP2 PROTEIN, HUMAN; MEMBRANE PROTEIN; NERVE PROTEIN;

ADULT; AGED; ALLERGIC ENCEPHALITIS; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; BLOOD LEVEL; BRAIN DISEASE; CEREBELLAR ATAXIA; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG MEGADOSE; FEMALE; FOLLOW UP; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORVAN SYNDROME; MYOKYMIA; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PARANEOPLASTIC NEUROPATHY; PLASMAPHERESIS; PRIORITY JOURNAL; PROMINENT LIMBIC DISEASE; RECURRENT DISEASE; RETROSPECTIVE STUDY; SEIZURE; SYNDROME; THYMOMA; CEREBROSPINAL FLUID; COMPLICATION; DIAGNOSTIC IMAGING; FRANCE; IMMUNOLOGY; MIDDLE AGED;

AGED; AUTOANTIBODIES; FEMALE; FOLLOW-UP STUDIES; FRANCE; HUMANS; ISAACS SYNDROME; LIMBIC ENCEPHALITIS; MAGNETIC RESONANCE IMAGING; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MYOKYMIA; NERVE TISSUE PROTEINS; RETROSPECTIVE STUDIES; SEIZURES; STEROIDS;

EID: 84999015224     PISSN: 21686149     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaneurol.2016.1585     Document Type: Article

References (19)

1. Irani SR, Alexander S, Waters P, et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-Associated protein-2 in limbic encephalitis, Morvans syndrome and acquired neuromyotonia. Brain. 2010;133(9):2734-2748.
2. Malter MP, Frisch C, Schoene-Bake JC, et al. Outcome of limbic encephalitis with VGKC-complex antibodies: relation to antigenic specificity. J Neurol. 2014;261(9):1695-1705.
3. Irani SR, Pettingill P, Kleopa KA, et al. Morvan syndrome: clinical and serological observations in 29 cases. Ann Neurol. 2012;72(2):241-255.
4. Laurencin C, André-Obadia N, Camdessanché JP, et al. Peripheral small fiber dysfunction and neuropathic pain in patients with Morvan syndrome. Neurology. 2015;85(23):2076-2078.
5. Poliak S, Salomon D, Elhanany H, et al. Juxtaparanodal clustering of Shaker-like K+ channels inmyelinated axons depends on Caspr2 and TAG-1. J Cell Biol. 2003;162(6):1149-1160.
6. Bel C, Oguievetskaia K, Pitaval C, Goutebroze L, Faivre-Sarrailh C. Axonal targeting of Caspr2 in hippocampal neurons via selective somatodendritic endocytosis. J Cell Sci. 2009;122(pt 18):3403-3413.
7. Pinatel D, Hivert B, Boucraut J, et al. Inhibitory axons are targeted in hippocampal cell culture by anti-Caspr2 autoantibodies associated with limbic encephalitis. Front Cell Neurosci. 2015;9:265.
8. Olsen AL, Lai Y, Dalmau J, Scherer SS, Lancaster E. Caspr2 autoantibodies target multiple epitopes. Neurol Neuroimmunol Neuroinflamm. 2015;2(4):e127.
9. Reiber H, Lange P. Quantification of virus-specific antibodies in cerebrospinal fluid and serum: sensitive and specific detection of antibody synthesis in brain. Clin Chem. 1991;37(7):1153-1160.
10. Navarro V, Kas A, Apartis E, et al. Motor cortex and hippocampus are the two main cortical targets in LGI1-Antibody encephalitis. Brain. 2016;139(pt 4): 1079-1093.
11. Lancaster E, Huijbers MG, Bar V, et al. Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia. Ann Neurol. 2011; 69(2):303-311.
12. Becker EBE, Zuliani L, Pettingill R, et al. Contactin-Associated protein-2 antibodies in non-paraneoplastic cerebellar ataxia. J Neurol Neurosurg Psychiatry. 2012;83(4):437-440.
13. Sunwoo JS, Lee ST, Byun JI, et al. Clinical manifestations of patients with CASPR2 antibodies. J Neuroimmunol. 2015;281:17-22.
14. Bindon CI, Hale G, Bröggemann M, Waldmann H. Human monoclonal IgG isotypes differ in complement activating function at the level of C4 as well as C1q. J Exp Med. 1988;168(1):127-142.
15. Bruhns P, Iannascoli B, England P, et al. Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses. Blood. 2009;113(16):3716-3725.
16. Schuurman J, Van Ree R, Perdok GJ, Van Doorn HR, Tan KY, Aalberse RC. Normal human immunoglobulin G4 is bispecific: it has two different antigen-combining sites. Immunology. 1999;97(4):693-698.
17. van der Neut Kolfschoten M, Schuurman J, Losen M, et al. Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange. Science. 2007;317(5844):1554-1557.
18. Huijbers MG, ZhangW, Klooster R, et al. MuSK IgG4 autoantibodies causemyasthenia gravis by inhibiting binding between MuSK and Lrp4. Proc Natl Acad Sci U S A. 2013;110(51):20783-20788.
19. Körtvelyessy P, Bauer J, Stoppel CM, et al. Complement-Associated neuronal loss in a patient with CASPR2 antibody-Associated encephalitis. Neurol Neuroimmunol Neuroinflamm. 2015;2(2):e75.